Luoyang Third People's Hospital

Luoyang 471002

5 studies enrolling now · 7 studies all time

What they study most

Atherosclerotic Cardiovascular Disease, Atrial Fibrillation, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Dyslipidemias, Familial Hypercholesterolemia, Heart Failure, High Cholesterol, Hypercholesterolemia, Hypertension, Kidney Disease, Chronic, Lipoprotein Disorder

Studies at this site

• EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease — Recruiting now
• A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart — Recruiting now
• A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure — Recruiting now
• Phase 2 Study of Kylo-11 in ASCVD Patients With Elevated Lp(a) — Recruiting now
• EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin) — Recruiting now
• A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation — Running, not enrolling
• Randomized Study to Evaluate the Effect of Obicetrapib on Top of Maximum Tolerated Lipid-Modifying Therapies — Completed